Delivery Order SPE2DB20D1100-SPE2DB24FA4F3
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, including the medication Nurtec ODT 75 mg tablets. The contract, valued at $40,257.64, is a firm fixed-price delivery order with a completion date of March 16, 2022. Amerisourcebergen, as a major pharmaceutical distributor, plays a critical role in supplying medical products to the federal government, particularly...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $22,268.88 delivery order is for the pharmaceutical product Nurtec ODT 75 mg tablets. The contract is a firm-fixed-price delivery order with a completion date of January 13, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $25,996.54 firm fixed-price delivery order is for the supply of Nurtec ODT 75 mg tablets. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nurtec ODT 75 mg tablets. The $3,591.60 firm fixed-price delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) on January 14, 2022. The $18,098.64 firm fixed-price delivery order is for the supply of Nurtec ODT 75 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nurtec ODT 75 mg tablets. The $12,960.69 firm-fixed-price delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of...
- This federal contract award is for the delivery of Nurtec ODT 75 mg tablets, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $31,448.82 firm-fixed-price delivery order falls under an Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as AmerisourceBergen), valued at up to $999,999,999 through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $14,574.44 for the pharmaceutical product Nurtec ODT 75 mg tablet. The award was issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. military. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Nurtec ODT 75 mg tablets. The $1,478.87 contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nurtec ODT 75 mg tablets. The contract, valued at $26,574.36, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to provide a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA4F3Delivery Order
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) to deliver Nurtec ODT 75 mg tablet packs. The $22,422.06 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen, a major pharmaceutical distributor, plays a critical role in supplying essential medical commodities such as specialty medications, generic drugs, and medical devices to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 2/27/24 |